Local News: Cambodia 

 | 

Sign Up

 | 

Sign In

Advertisment

DTIC-Dome, Dacarbazine

DTIC-Dome, Dacarbazine News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make DTIC-Dome, Dacarbazine News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

DTIC-Dome, Dacarbazine News

News on DTIC-Dome, Dacarbazine (generic) continually updated from thousands of sources around the net.

Oct 29, 2009 | Drugs.com

Genta Announces Top-Line Results of AGENDA Phase 3 Trial of Genasense ...

Oct 29, 2009 - Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense Injection in patients with advanced melanoma.

Comment?

Related Topix: Biotech, Medicine, Genta, Healthcare Industry, Medication

Fri Aug 14, 2009

Freshnews

Genta Incorporated Announces Second Quarter 2009 Financial Results

Genta Incorporated today announced financial results for the quarter ended June 30, 2009.

Comment?

Related Topix: Biotech, Medicine, Genta, Healthcare Industry, Medication

Tue Jul 14, 2009

Med Ad News

New Publication Confirms Critical Link of LDH Biomarker in Genasense...

BERKELEY HEIGHTS, NJ July 14, 2009 Genta Incorporated announced publication of a paper that independently confirms the link of a key biomarker to overall survival in patients with advanced melanoma.

Comment?

Related Topix: Biotech, Medicine, Genta, Healthcare Industry, Berkeley Heights, NJ, Medication

Wed Jun 03, 2009

Drugs.com

Genasense Combined with Temodar and Abraxane Shows Preliminary...

Jun 3, 2009 - Genta Incorporated announced preliminary results that show a high objective response rate and potentially extended survival in an ongoing pilot study that incorporates the Company's lead oncology product, Genasense Injection, in a chemotherapy program for patients with advanced melanoma.

Comment?

Related Topix: Medicine, Temodar, Temozolomide (generic), Medication, Biotech, Genta, Healthcare Industry, Oncology

Also on Topix